Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan

BACKGROUND/AIMS: Anti-tumor necrosis factor drugs (anti-TNF) and thiopurines are important treatment options in patients with inflammatory bowel disease (IBD), including during pregnancy. However, there are limited data on the benefit/risk profile of anti-TNF and thiopurines during pregnancy in Asia...

Descripción completa

Detalles Bibliográficos
Autores principales: Komoto, Shunsuke, Motoya, Satoshi, Nishiwaki, Yuji, Matsui, Toshiyuki, Kunisaki, Reiko, Matsuoka, Katsuyoshi, Yoshimura, Naoki, Kagaya, Takashi, Naganuma, Makoto, Hida, Nobuyuki, Watanabe, Mamoru, Hibi, Toshifumi, Suzuki, Yasuo, Miura, Soichiro, Hokari, Ryota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863047/
https://www.ncbi.nlm.nih.gov/pubmed/27175114
http://dx.doi.org/10.5217/ir.2016.14.2.139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863047/
https://www.ncbi.nlm.nih.gov/pubmed/27175114
http://dx.doi.org/10.5217/ir.2016.14.2.139

Ejemplares similares